Hydroxyurea Exposure Limiting Pregnancy and Follow-Up Lactation

Abroad (travel likely)Recruiting

Conditions

Sickle Cell Disease · Sickle Cell Anemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Contact: Study coordinator (Teresa Latham) · Teresa.Latham@cchmc.org · 513-803-7922
Contact: Study coordinator (Rebecca Geer) · Rebecca.Geer@cchmc.org

Study leads

Russell Ware, MD
Principal Investigator
Children's Hospital Medical Center, Cincinnati

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Alendronate for Osteonecrosis in Adults With Sickle Cell Disease

Sickle Cell Disease · Sickle Cell Anemia · Osteonecrosis

Abroad (travel likely)RecruitingPHASE2

Sacramento, United States

Optimizing Hydroxyurea Therapy in Children With Sickle Cell Anemia In Malaria Endemic Areas: The NOHARM Maximum Tolerated Dose (MTD) Study

Sickle Cell Disease · Sickle Cell Anemia in Children

Abroad (travel likely)RecruitingPHASE1, PHASE2

Kampala, Uganda

Tocilizumab for Acute Chest Syndrome

Sickle Cell Disease · Acute Chest Syndrome

Abroad (travel likely)RecruitingPHASE2

Chicago, United States

mAnaging siCkle CELl disEase Through incReased AdopTion of hydroxyurEa in Nigeria

Sickle Cell Disease

Abroad (travel likely)Recruiting

Abuja, Nigeria